Patients with STGD1 commonly present with progressive bilateral central vision loss ... loss was 1.6-fold greater than the area of RPE atrophy, which suggests that photoreceptor degeneration may ...

AI-powered research on one of the largest eye studies to date has created the most detailed maps of the retina ever produced.

Occasionally, treatments come along that are of greater interest to patients than to doctors.Drops for treating presbyopia ...

In the trial, subjects treated with the Eylea HD 8mg injection every eight weeks showed non-inferior visual acuity gains.

Astellas has suffered another major setback with geographic atrophy (GA) treatment Izervay, this time in the US. The company has received a complete response letter (CRL) from the FDA for a ...

Australia has become the first country outside of the United States to approve the use of the drug pegcetacoplan (SYFOVRE) to slow down the progression of geographic atrophy.

4D Molecular Therapeutics announced it will present the initial interim 52-week data from the Phase 2b Population Extension cohort of the PRISM clinical trial. The trial is evaluating 4D-150 in a ...

Panelists discuss how both medications demonstrate favorable safety profiles in clinical trials, with aflibercept 8 mg benefiting from extensive 2-mg safety data, while acknowledging the need to ...